From the Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (Y.H., X.L., L.Q.).
Clinical and Translational Epidemiology Unit (W.M., A.T.C.), Massachusetts General Hospital and Harvard Medical School, Boston.
Circ Res. 2020 Jan 31;126(3):364-373. doi: 10.1161/CIRCRESAHA.119.315279. Epub 2019 Dec 17.
The overuse of antibiotics has been an important clinical issue, and antibiotic exposure is linked to alterations in gut microbiota, which has been related to risks of various chronic diseases such as cardiovascular disease and cancer. Also, duration of antibiotic exposure may be a risk factor of premature death. We investigated associations of life-stage and duration of antibiotic use during adulthood with risks of all-cause and cause-specific mortality. This prospective cohort study included 37 516 women aged ≥60 years who were free of cardiovascular disease or cancer from the Nurses' Health Study. Participants reported a total amount of time they used antibiotics (none, <15 days, 15 days to <2 months, or ≥2 months) in the middle- (age, 40-59) and late adulthood (age, 60 or older). We estimated hazard ratios for all-cause mortality and deaths from cardiovascular disease or cancer over 10 years according to duration of antibiotic use. During 355 918 person-years of follow-up, we documented 4536 deaths from any cause (including 728 cardiovascular deaths and 1206 cancer deaths). As compared with women who did not use antibiotics, those who used them for ≥2 months in late adulthood had increased risks of all-cause mortality (hazard ratio, 1.16 [95% CI, 1.01-1.33]) and cardiovascular mortality (hazard ratio, 1.49 [95% CI, 1.04-2.13]), but not cancer mortality (hazard ratio, 0.85 [95% CI, 0.65-1.12]) after adjustment for chronic metabolic diseases, antibiotic use during middle adulthood, indication for use, demographic factors, and lifestyle/dietary factors. The association was more evident among women who also used antibiotics in middle-adulthood than among those who did not use during this life-stage. Long-term use of antibiotics in late adulthood may be a risk factor for all-cause and cardiovascular mortality. The unfavorable effect of antibiotic exposure for subsequent risks of deaths due to chronic diseases needs to be considered.
抗生素的过度使用一直是一个重要的临床问题,抗生素的暴露与肠道微生物群的改变有关,而肠道微生物群的改变与各种慢性疾病(如心血管疾病和癌症)的风险有关。此外,抗生素暴露的持续时间可能是早逝的一个风险因素。我们研究了成年期不同生命阶段和抗生素使用时间与全因和特定原因死亡率的关系。这项前瞻性队列研究纳入了来自护士健康研究的 37516 名年龄≥60 岁、无心血管疾病或癌症的女性。参与者报告了他们在中年(年龄 40-59 岁)和老年(年龄 60 岁或以上)期间使用抗生素的总时间(无、<15 天、15 天至<2 个月或≥2 个月)。我们根据抗生素使用时间估计了 10 年内全因死亡率和心血管疾病或癌症死亡率的风险比。在 355918 人年的随访期间,我们记录了 4536 例任何原因导致的死亡(包括 728 例心血管死亡和 1206 例癌症死亡)。与未使用抗生素的女性相比,在老年期使用抗生素≥2 个月的女性全因死亡率(风险比,1.16 [95%CI,1.01-1.33])和心血管死亡率(风险比,1.49 [95%CI,1.04-2.13])的风险增加,但癌症死亡率(风险比,0.85 [95%CI,0.65-1.12])没有增加,经慢性代谢性疾病、中年期抗生素使用、用药指征、人口统计学因素和生活方式/饮食因素调整后。在中年期也使用抗生素的女性中,这种关联比未在该生命阶段使用抗生素的女性更明显。老年期长期使用抗生素可能是全因和心血管死亡率的一个风险因素。抗生素暴露对随后因慢性疾病导致的死亡风险的不利影响需要考虑。